Orbital lymphoma: Role of radiation

Indian Journal of Ophthalmology

Volumn 57, Issue 2, 2009, Pages 91-97

  Yadav, B S ^a   Sharma, S C ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Chemotherapy; Lymphoma; Orbit; Radiation therapy

Indexed keywords

ARTICLE; FACTUAL DATABASE; HUMAN; NONHODGKIN LYMPHOMA; ORBIT TUMOR; PATHOLOGY; TREATMENT OUTCOME;

DATABASES, FACTUAL; HUMANS; LYMPHOMA, NON-HODGKIN; ORBITAL NEOPLASMS; TREATMENT OUTCOME;

EID: 61349169683     PISSN: 03014738     EISSN: 19983689     Source Type: Journal    
DOI: 10.4103/0301-4738.44516     Document Type: Article

References (49)

1. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer 1972;29:252-60.
2. Fitzpatrick PJ, Macko S. Lymphoreticular tumors of the orbit. Int J Radiat Oncol Biol Physics 1984;10:333-40.
3. Bessel EM, Henk JM, Wright JE, Whitelocke RA. Orbital and conjunctival lymphoma: Treatment and prognosis. Radither Oncol 1988;13:237-44.
4. Coupland SE, Hummel M, Stien H. Ocular adnexal lymphomas: Five case presentation and a review of literature. Surv Ophthalmol 2002;47:470-90.
5. Fung CY, Tarbell NJ, Lucarelli MJ, Goldberg SI, Linggood RM, Harris NL, et al. Ocular adnexal Lymphoma: Clinical behaviour of distinct world health organization classification of subtypes. Int J Rad Oncol Biol Phys 2003;57:1382-91.
6. Smitt MC and Donaldson SS. Radiotherapy is successful treatment for orbital lymphoma. Int J Radiat Oncol Biol Physics 1993;26:59-66.
7. Mittal BB, Deutrch M, Kennerdell J, Johnson B. Paraocular lymphoid tumors. Radiology 1986;159:793.
8. Esik O, Ikeda H, Mukai K, Kaneko A. A retrospective analysis of different modalities for treatment of primary orbital non-Hodgkins lymphoma. Radiother Oncol 1996;38:13-8.
9. Tsang RW, Gospodarowicz MK, Pintilie M , Wells W, Hodgson DC, Sun A. Localized mucosa- associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol 2003;21:4157-64.
10. Reddy EK, Bhatia P, Evans RG. Primary orbital lymphomas. Int J Radiat Oncol Biol Phys 1984;10:1013-9.
11. rd, Maiese RL, Almasri NM, et al. Radiotherapy in the management of orbital lymphoma. Int J Radiat Oncol Biol Phys 1999;44:31-6.
12. Stafford SL, Kozelsky TF, Garrity JA, Kurtin PJ, Leavitt JA, Martenson JA, et al. Orbital lymphoma: Radiotherapy outcome and complications. Radither Oncol 2001;59:139-44.
13. Kim Y, Fayos J. Primary orbital lymphoma: A radiotherapeutic experience. Int J Radiat Oncol Biol Phys 1976;1:1099-105.
14. Chao CK, Lin HS, Devineni VR, Smith M. Radiation therapy for primary orbital lymphoma. Int J Radiat Oncol Biol Phys 1995;31:929-34.
15. Lister TA, Crowther D, Surclffe SB, Glatstein E, Canellos GP, Young RC,. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 1989;7:1630-6.
16. Ferreri AJ, Ponzoni M, Guidoboni M, Conciliis De C, Resti AG, Mazzi B, et al. Regression of ocular adnexal lymphoma after chlamydia psittaci-eradicating antibiotic therapy. J Clin Oncol 2005;23:5067-73.
17. Grünberger B, Hauff W, Lukas J, Wohrer S, Zielinski CC, Streubel B, et al. 'Blind' antibiotic treatment targeting Chlamydia is not effective in patients with MALT lymphoma of the ocular adnexal. Ann Oncol 2006;17:484-7.
18. Husain A, Roberts D, Pro B, McLaughlin P, Esmaeli B. Metaanalysis of the association between Chlamydia psittaci and ocular adnexal lymphoma and the response of ocular adnexal lymphoma to antibiotics. Cancer 2007;110:809-15.
19. Freire JE, Brady LW, Shields JA, Shields CL. Eye and orbit. In: Perez CA, Halperin EC, Schmidt-Ullrich RK, editors. Principles and practice of radiation oncology. Philadelphia: Lippincott Williams and Wilkins; 2004. p. 888.
20. Freire JE, Brady LW, Shields JA, Shields CL. Non-Hodgkin's lymphoma. In: Perez CA, Halperin EC, Schmidt-Ullrich RK, editors. Principles and practice of radiation oncology. Philadelphia: Lippincott Williams and Wilkins; 2004. p. 2096.
21. Donaldson SS, Findley DO. Treatment of orbital lymphoid tumors with electron beams. Front Radiat Ther Oncol 1991;25:187-200.
22. Purdy JA. Three-dimensional conformal radiation therapy: Physics, treatment planning and clinical aspects. In: Principles and practice of radiation oncology. Philadelphia: Lippincot Williams and Wilkins; 2004. p. 283-313.
23. Mohan R, Low D, Chao KS. Intensity-Modulated radiation treatment planning, quality assurance, delivery and clinical application. In: Principles and practice of radiation oncology. Philadelphia: Lippincot Williams and Wilkins; 2004. p. 314-36.
24. Foster SC, Wilson CS, Tret er PK. Radiotherapy of the primary lymphoma of the orbit. Am J Roentgenol Radium Ther Nucl Med 1971;111:343-49.
25. Jereb B, Lee H, Jackobiec FA, Kutcher J. Radiation therapy of conjunctival and orbital lymphoid tumors. Int J Radiat Oncol Biol Phys 1984;10:1013-9.
26. Kamath SS, Marcus RB Jr., Lynch JW The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in stage I and II non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys1999;44:563-8.
27. Letschert JG, Gonazales Gonazales D, Oskam J, Koornneef L, van D?k JD, Boukes R, et al. Results of radiotherapy in patients with stage-I orbital non-Hodgkin's lymphoma. Radiother Oncol 1991;22:36-44.
28. Pelloski CE, Wilder RB, Ha CS, Hess MA, Cabanillas FF, Cox JD. Clinical stage IEA-IIEA orbital lymphomas: Outcomes in the era of modern staging and treatment. Radither Oncol 2001;59:145-51.
29. Palatias LC, Putterman AM, Vijayakumar S, Recant W, Weichselbaum RR, Bitran JD. Treatment and prognosis of orbital non-Hodgkin's lymphomas. Am J Clin Oncol 1992;15:79-83.
30. Bhatia S, Paulino AC, Buat i JM, Mayr NA, Wen BC. Curative radiotherapy for orbital lymphoma. Int J Radiat Oncol Biol Phys 2002;54:818-23.
31. Bolek TW, Moyses HM, Marcus RB Jr. Radiotherapy for primary orbital lymphoma. Int J Radiat Oncol Biol Phys 1995;31:929-34.
32. Uno T, Isobe K, Shikama N, Nishikawa A, Oguchi M, Ueno N, et al. Radiotherapy for extranodal marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: A multi-institutional retrospective review of 50 patients. Cancer 2003;98:865-71.
33. Martinet S, Ozsahin M, Belkacemi Y, Landmann C, Poortmans P, Oehlere C. Outcome and prognostic factors in orbital lymphoma: A Rare Cancer Network study on 90 consecutive patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 2003;55:892-8.
34. Pfeff er MR, Rabin T, Tsvang L, Goff man J, Rosen N, Symon Z. Orbital lymphoma: Is it necessary to teat the entire orbit? Int J Radiat Oncol Biol Phys 2004;61:527-30.
35. White WL, Ferry JA, Harris NL, Grove AS Jr. Ocular adnexal lymphoma: A clinicopathologic study with identification of lymphomas of mucosa associated lymphoid tissue type. Ophthalmology 1995;102:1994-2006.
36. Hardman-Lea S, Kerr-Muir M, Wotherspoon AC, Green WT, Morell A, Isaacson PG. Mucosa associated lymphoid tissue lymphoma of the conjunctiva. Arch Ophthalmol 1994;112:1207-12.
37. Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma. N Engl J Med 2002;346:235-42.
38. Avilés A, Neri N, Calva A, Huerta-Guzmán J, Cleto S, Nambo MJ. Addition of a short course of chemotherapy did not improve outcome in patients with localized marginal B-cell lymphoma of the orbit. Oncology 2006;70:173-6.
39. Harris NL, Jaffe ES, Stein H. A Revised European-American classifications of lymphoid neoplasms: A proposal from International Lymphoma Study Group. Blood 1994;84:1361-92.
40. Minehan KJ, Martenson JA Jr, Garriyt JA, Kurtin PJ, Banks PM, Chen MG, et al. Local control and complications after radiation therapy for primary orbital lymphoma: A case for low dose treatment. Int J Radiat Oncol Biol Phys 1991;20:791-6.
41. A predictive model for aggressive non-Hodgkin's lymphoma: The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Eng J Med 1993;329:987-94.
42. Hasegawa M, Kojima M, Shioya M, Tamaki Y, Saitoh JI, Sakurai H, et al. Treatment results of radiotherapy for malignant lymphoma of the orbit and histopathological review according to the WHO classification. Int J Radiat Oncol Biol Phys 2003;57:172-6.
43. Zhou P, Andrea K, Silver B, Li S, Hua L, Mauch PM. Radiation therapy for orbital lymphoma. Int J Radiat Oncol Biol Phys 2005;63:866-71.
44. Ejima Y, Sasaki R, Okamoto Y, Maruta T, Azumi A, Hayashi Y, et al. Ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy. Radither Oncol 2005;78:6-9.
45. Bischof M, Karagiozidis M, Krempien R, Treiber M, Neuhof D, Debus J, et al. Radiotherapy for orbital lymphoma outcome and late effects. Strahlenther Onkol 2007;183:17-22.
46. Quyn-Thu Le, Stephen ME, Tracy IG, Richard H, Warnke RA, Donaldson SS, et al. Primary radiotherapy for localized orbital malt lymphoma. Int J Radiat Oncol Biol Phys 2002;52:657-63.
47. Jakobiec FA, Iwamot o T, Patell M, Knowles DM 2nd. Ocular adnexal monoclonal lymphoid tumors with a favorable prognosis. Ophthalmology 1986;93:1574-7.
48. Dunbar S, Linggood R, Doppke K, Duby A, Wang CC. Conjunctival lymphoma: Results and treatment with a single anterior electron field, A lens sparing approach. Int J Radiat Oncol Biol Phys 1990;19:249-57.
49. Gordon KB, Char DH, Sangerman RH. Late effects of radiation on the eye and ocular adnexal. Int J Radiat Oncol Biol Phys 1995;31:1123-39.